This article is more than 5 years old. Information may no longer be current.
Bacterin receives patent for method to produce demineralized bone matrix
Click Here to Manage Email Alerts
Bacterin International Holdings Inc. has announced that the company has received patent from the U.S. Patent and Trademark Office for a method to produce a demineralized cancellous bone matrix, such as Bacterin’s OsteoSponge product line.
According to a company press release, Bacterin also has a pending divisional application in the United States to pursue protection on other aspects of its bone demineralization technology and is pursuing protection on related applications in Canada, Europe and Korea.
“We are pleased to receive this patent that protects our proprietary demineralized bone products and recognizes the long-term innovation of our company,” Gregory Juda, chief scientific officer of Bacterin, stated in the release. “This patent further substantiates our core competency in demineralized bone matrix technology and we are committed to maintaining our role as a leader in advancing orthobiologic technology.”